This document is a conclusive presentation that encompasses the perspective of antipsychotic reduction initiatives in the medical field.
Slides are as followed:
- Faculty Disclosure
- Learning Objectives
- National Priority
- FDA approved diagnoses
- Common Off-label uses
- Effectiveness in Dementia
- Etc.